This is the PrivCo Investor Profile for Fidelity Biosciences
This profile is intended to help you find and contact investors, see private market deal activity, and view private company ownership for the investor Fidelity Biosciences.
To unlock all information in this profile: Upgrade to PrivCo Premium

Fidelity Biosciences

What's included with your PrivCo Premium Subscription:
Next Actions on Fidelity Biosciences:
View Deal ActivityView Direct E-mail Contacts

Investor Summary

Fidelity Biosciences is a venture capital firm that specializes in early stage investments. Fidelity Biosciences was founded in 2002 and is headquartered in Cambridge, Massachusetts.  Fidelity Biosciences in a corporate venture capital arm of investment manager Fidelity Investments.

Investor Overview

Basic Information

Investor Type:Venture Capital
Parent:Fidelity Investments
Year Founded:2002
Address:1 Main Street
13th Floor
City:Cambridge
State/Province:Massachusetts
Country:United States
Phone:View
Fax:View
Website:www.fidelitybiosciences.com

Investment Preferences

Preferred Stage:Seed
Early Stage
Mid Stage / Expansion

Investor Contacts

Below are direct e-mail contacts for senior professionals at Fidelity Biosciences.
Full contact details are available with a PrivCo Premium Subscription.
Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
NameTitle
Thomas R. BeckVenture Partner
Eric GoldingSenior Analyst
Ben AuspitzPrincipal
Wei LiPrincipal
Stephen KnightManaging Partner

Private Deal History

This table is intended to portray Fidelity Biosciences PrivCo-covered market activity. Click below for Deal Details and Private Company Reports.
All data before 2006 is completely free to view! To access data from 2006 onward:
Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateTargetTarget IndustryDeal TypeTotal Deal AmountStatus
Apr. 2013ViewHealth Care Providers & Related Medical ServicesFundingViewCompletedDetails
Mar. 2013ViewPsychiatric, Behavioral & Mental Health ServicesFundingViewCompletedDetails
Jan. 2013ViewHealth & Medical SoftwareFundingViewCompletedDetails
Dec. 2012ViewPharmaceuticalsFundingViewCompletedDetails
Nov. 2012ViewBiopharmaceuticalsFundingViewCompletedDetails
Oct. 2012ViewPharmaceutical & Drug Manufacturing
Pharmaceutical Research & Drug Discovery		FundingViewCompletedDetails
Oct. 2012ViewDrug Delivery Technology
Pharmaceuticals		AcquisitionViewCompletedDetails
Aug. 2012ViewSoftwareFundingViewCompletedDetails
Jul. 2012ViewPharmaceuticalsFundingViewCompletedDetails
Jul. 2012ViewPharmaceuticalsFundingViewCompletedDetails
Apr. 2012ViewFinancial & Accounting SoftwareFundingViewCompletedDetails
Mar. 2012ViewMedical Device & Equipment Manufacturing
Other Medical Devices & Equipment		FundingViewCompletedDetails
Oct. 2011ViewBiotechnologyFundingViewCompletedDetails
Oct. 2011ViewHealth Care Providers & Related Medical ServicesFundingViewCompletedDetails
Aug. 2011ViewMedical Device & Equipment Manufacturing
Other Medical Devices & Equipment		FundingViewCompletedDetails
Aug. 2011ViewMedical Devices & EquipmentFundingViewCompletedDetails
Jul. 2011ViewPharmaceuticalsAcquisition
Asset Sale		ViewCompletedDetails
Jun. 2011ViewPharmaceuticalsFundingViewCompletedDetails
Jan. 2011ViewPharmaceuticalsFundingViewCompletedDetails
2011ViewBiopharmaceuticalsFundingViewCompletedDetails
Dec. 2010ViewDrug Delivery TechnologyFundingViewCompletedDetails
Oct. 2010ViewBiotechnologyFundingViewCompletedDetails
Aug. 2010ViewMedical Device & Equipment Manufacturing
Other Medical Devices & Equipment		FundingViewCompletedDetails
Jun. 2010ViewOther Biotechnology
Pharmaceuticals		FundingViewCompletedDetails
Jun. 2010ViewBiotechnologyFundingViewCompletedDetails
May. 2010ViewBiopharmaceuticalsFundingViewCompletedDetails
Oct. 2009ViewOther Biotechnology
Pharmaceuticals		FundingViewCompletedDetails
Sep. 2009ViewDrug Delivery Technology
Pharmaceuticals		FundingViewCompletedDetails
Sep. 2009ViewPharmaceuticalsFundingViewCompletedDetails
Jul. 2009ViewBiotechnologyFundingViewCompletedDetails
Jun. 2009ViewDrug Delivery TechnologyFundingViewCompletedDetails
Jun. 2009ViewPharmaceuticalsFundingViewCompletedDetails
Mar. 2009ViewOther Healthcare
Supplementary Medicine & Nutrition		FundingViewCompletedDetails
Oct. 2008ViewDrug Delivery Technology
Pharmaceuticals		FundingViewCompletedDetails
Oct. 2008ViewBiochemicals
Pharmaceuticals		FundingViewCompletedDetails
Aug. 2008ViewDrug Delivery TechnologyFundingViewCompletedDetails
Aug. 2008ViewOther Biotechnology
Pharmaceuticals		FundingViewCompletedDetails
Aug. 2008ViewMedical Device & Equipment Manufacturing
Other Medical Devices & Equipment		FundingViewCompletedDetails
Mar. 2008ViewDrug Delivery Technology
Pharmaceuticals		FundingViewCompletedDetails
Dec. 2007ViewBiotechnologyFundingViewCompletedDetails
Dec. 2007ViewDrug-Related Products
Other Pharmaceuticals		FundingViewCompletedDetails
Aug. 2006ViewOther Biotechnology
Pharmaceuticals		FundingViewCompletedDetails
Aug. 2006ViewOther Healthcare
Supplementary Medicine & Nutrition		FundingViewCompletedDetails
Nov. 2005Mersana Therapeutics, Inc.PharmaceuticalsFunding$21,000,000CompletedDetails

Supplemental Resources

For additional information on Fidelity Biosciences, or on private company investing, you can see the following:
What's included with your PrivCo Premium Subscription:
Next Actions on Fidelity Biosciences:
View Deal ActivityView Direct E-mail Contacts
  • Learn More About PrivCo
  • PrivCo’s Clients Include:
  • Clients Include: Motorola, 3M, Samsung, Oracle, TATA, Johnson and Johnson, CB Richard Ellis
  • PrivCo Is Featured In:
  • Featured In: The New York Times, New York Post, Bloomberg, CNBC, NPR, The Washington Post, The Wall Street Journal, CNN, Fortune, BusinessWeek, Reuters, CBS News, USA Today
PrivCo’s 300-page Private Company Tech M&A Report for 2012 - Click Here For Full Report
  • Quick Investor Search

within miles
Go to Advanced Search
  • What is PrivCo?

PrivCo is the authority for financial & business data on major private market investors, including:

PrivCo Private Deals Newsletter.
It's FREE!

This is the PrivCo Investor Profile for Fidelity Biosciences
This profile is intended to help you find and contact investors, see private market deal activity, and view private company ownership for the investor Fidelity Biosciences.
To unlock all information in this profile: Upgrade to PrivCo Premium